Mark S Segal Selected Research

Mark S Segal Research Topics

Disease

8	Chronic Renal Insufficiency 01/2024 - 03/2013
8	Hypertension (High Blood Pressure) 08/2021 - 07/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2005
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2010 - 01/2006
6	Kidney Diseases (Kidney Disease) 01/2022 - 10/2007
6	Inflammation (Inflammations) 01/2021 - 03/2005
5	Sepsis (Septicemia) 01/2022 - 08/2017
4	Critical Illness (Critically Ill) 01/2022 - 08/2017
4	Ischemia 01/2020 - 01/2006
4	Lupus Nephritis 01/2019 - 06/2004
3	Chronic Kidney Failure (Chronic Renal Failure) 09/2021 - 12/2016
3	Atherosclerosis 01/2021 - 01/2015
3	Albuminuria 01/2021 - 07/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 10/2007
3	Hyperplasia 06/2017 - 06/2005
3	Obesity 12/2013 - 10/2007
2	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 11/2013
2	Vascular Diseases (Vascular Disease) 08/2021 - 01/2012
2	Neoplasms (Cancer) 03/2020 - 01/2019
2	Hyperuricemia 08/2015 - 07/2004
2	Essential Hypertension 04/2010 - 07/2005
2	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2009 - 12/2004
2	Rheumatoid Arthritis 12/2009 - 02/2007
2	Neointima 03/2008 - 06/2005
1	Fabry Disease (Fabry's Disease) 11/2021
1	Insulin Resistance 01/2021
1	COVID-19 07/2020
1	Leukemia 03/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2020
1	Anemia 01/2020
1	Hyperemia 01/2020
1	Proteinuria 01/2019
1	Opiate Overdose 01/2019
1	Hematuria 06/2018
1	Multiple Organ Failure (MODS) 01/2018
1	Acute Pain 01/2018
1	Muscular Diseases (Myopathy) 01/2018
1	Candidiasis (Moniliasis) 01/2018
1	Sleep Wake Disorders 01/2018
1	Shock 01/2018
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 10/2017
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 05/2017
1	Disease Progression 05/2017

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2006
4	CreatinineIBA 01/2024 - 01/2009
4	Interferon Type IIBA 02/2016 - 11/2007
3	DiureticsIBA 08/2021 - 07/2004
3	Antihypertensive Agents (Antihypertensives)IBA 08/2021 - 01/2018
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 01/2015
3	erucylphosphocholineIBA 01/2020 - 01/2006
3	Retinaldehyde (Retinal)IBA 06/2017 - 01/2005
3	Uric Acid (Urate)IBA 08/2014 - 07/2005
3	AutoantibodiesIBA 01/2010 - 01/2006
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2020
2	LipidsIBA 01/2022 - 01/2015
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2021 - 01/2019
2	Angiotensin Receptor AntagonistsIBA 08/2021 - 01/2019
2	AntibodiesIBA 03/2020 - 12/2009
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 10/2017
2	Antigen-Antibody Complex (Immune Complex)IBA 05/2017 - 01/2009
2	Glucose (Dextrose)FDA LinkGeneric 04/2009 - 10/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2009 - 12/2004
2	FructoseIBA 10/2007 - 10/2007
2	SugarsIBA 10/2007 - 10/2007
2	ChemokinesIBA 01/2006 - 12/2004
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2005 - 06/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2005 - 12/2004
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Lysergic Acid Diethylamide (LSD)IBA 11/2021
1	GalactosidasesIBA 11/2021
1	Messenger RNA (mRNA)IBA 10/2020
1	Complement System Proteins (Complement)IBA 10/2020
1	Epithelial Cell Adhesion MoleculeIBA 03/2020
1	UromodulinIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	roxadustatIBA 01/2020
1	BenzodiazepinesIBA 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Hydroxocobalamin FDA Link 06/2018
1	Erythropoietin FDA Link 01/2018
1	ChloridesIBA 01/2018
1	Chlorthalidone (Chlortalidone)FDA LinkGeneric 08/2015
1	ThiazidesIBA 08/2015
1	Potassium Chloride FDA LinkGeneric 08/2015
1	Xanthine OxidaseIBA 08/2015
1	4-cresol (p-cresol)IBA 05/2015
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	AdiponectinIBA 03/2015
1	salicylhydroxamic acid (SHAM)IBA 01/2015
1	AldosteroneIBA 12/2013
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 12/2013
1	Eplerenone (Inspra)FDA LinkGeneric 12/2013
1	antineoplaston A10 (A 10)IBA 11/2013

Therapy/Procedure

8	Therapeutics 09/2021 - 09/2008
3	Renal Dialysis (Hemodialysis) 01/2022 - 03/2005
3	Critical Care (Surgical Intensive Care) 01/2018 - 08/2017
2	Resuscitation 01/2018 - 08/2017
1	Traction 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2016